short sellers

Filed under: , , , ,

LeapFrog (LF) logoLeapFrog Enterprises (LF) plummeted more than 25% this morning, after the company warned that its full-year earnings will fall below Wall Street’s expectations. The maker of educational toys expects to bank a profit of 3 cents to 6 cents per share for fiscal 2010, way below analysts’ consensus estimate of 28 cents per share.

“After a solid start to the holiday season, demand softened late in the quarter relative to our expectations,” explained CEO Bill Chiasson. “While sales of interactive reading products continued to grow at retail, the growth was less than we had forecasted and contributed to lower earnings growth than expected.”

Continue reading LeapFrog Takes a Nosedive on Weak FY Forecast

LeapFrog Takes a Nosedive on Weak FY Forecast originally appeared on BloggingStocks on Wed, 12 Jan 2011 14:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Filed under: , ,

Garmin (GRMN)Thursday morning, GPS specialist Garmin Ltd. (GRMN) said it lost a patent dispute with Japanese firm Pioneer Corp. The District Court of Dusseldorf in Germany found that two patents owned by Pioneer were infringed by a certain functionality in Garmin’s software.

However, Garmin says it has already worked out “minor software revisions that eliminate the narrow functionality at issue in the litigation.” As a result, the company doesn’t expect any significant impact on its ability to import and sell its navigational products.

Continue reading Garmin Slumps After Patent Defeat

Garmin Slumps After Patent Defeat originally appeared on BloggingStocks on Thu, 23 Dec 2010 12:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags:

Filed under: , , ,

Cumberland Pharmaceuticals (CPIX) logoShares of Cumberland Pharmaceuticals (CPIX) are having a rough go of it after the Food and Drug Administration (FDA) outlined some concerns that will further delay a ruling on its liver drug. The regulatory agency already postponed its decision from August to December, and now the FDA says it needs additional data before it can recommend the drug for approval.

In its complete response letter to Cumberland, the FDA noted insufficient evidence to prove that the injectable drug, Acetadote, is effective in all patients. Cumberland said it plans to meet with the FDA soon to address the outstanding issues.

Continue reading Cumberland Pharma Plummets After FDA Rejection

Cumberland Pharma Plummets After FDA Rejection originally appeared on BloggingStocks on Wed, 22 Dec 2010 13:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags:

Filed under: , , ,

Netflix (NFLX) logoShares of Netflix (NFLX) started Tuesday on a high note, with the shares gaining more than 1% out of the gate. Traders appear to be responding to new comments from Jim Cramer, after the host of CNBC’s Mad Money offered an upbeat opinion on the stock Monday.

Specifically, Cramer is enthusiastic about Netflix’s push into streaming content, and he has high expectations for future subscriber growth. The analyst also argued that the stock’s valuation is actually quite reasonable, when measured against the company’s long-term growth rate. For traders looking to take part in continued gains by NFLX, Cramer suggested in-the-money call options.

Continue reading Netflix Gains Ground on Cramer Recommendation

Netflix Gains Ground on Cramer Recommendation originally appeared on BloggingStocks on Tue, 21 Dec 2010 13:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati